TIMELINE
2024
2023
2022
2021
2020
2018
2017
2016
2015
PARTNERING
As we continue to develop novel therapies to improve outcomes for patients. We are open to new partnerships with academic and scientific organizations.
Positive Interim Phase 2 Data of Elraglusib in pancreatic cancer
Initial Public Offering
Initiation of FOLFIRINOX Trial
Actuate announces FDA fast track designation for 9-ING-41 in the treatment of pancreatic cancer.
Actuate announces the primary endpoint was met in the 9-ING-41 Phase 2 study in pancreatic cancer.
Actuate announces initiation of Phase 2 clinical study in pancreatic cancer.
The FDA accepts Actuate’s IND application for 9-ING-41 with clearance to proceed with clinical study in patients with advanced cancers.
Actuate treats first patient in Phase 1 / 2 Clinical Study of 9-ING-41 in patients with refractory cancers.
Actuate technologies are featured in the Molecular Pathways section of the journal Clinical Cancer Research.
FDA grants 9-ING-41 an additional orphan drug designation for the treatment of neuroblastoma.
Food and Drug Administration grants 9-ING-41 an orphan drug designation for the treatment of glioblastoma.
The company is incorporated as Apotheca Therapeutics, Inc.
Actuate forms a Scientific Advisory Board.
As we continue to develop novel therapies to improve outcomes for patients. We are open to new partnerships with academic and scientific organizations.
| Cookie | Duration | Description |
|---|---|---|
| GetLocalTimeZone | session | No description |
| PHPSESSID | session | This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed. |
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| elementor | never | This cookie is used by the website's WordPress theme. It allows the website owner to implement or change the website's content in real-time. |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
| Cookie | Duration | Description |
|---|---|---|
| _ga | 2 years | The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors. |
| _ga_7GWH3VTDXR | 2 years | This cookie is installed by Google Analytics. |